Clinical Trials Directory

Trials / Completed

CompletedNCT03214497

Protector™ Versus Supreme® Laryngeal Mask Airway

Prospective Randomised Trial of the Protector™ Versus the Supreme® Laryngeal Mask Airway

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Schulthess Klinik · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to compare the oropharyngeal leak pressure of the Protector Laryngeal mask with the Supreme laryngeal mask. Other secondary parameters will be studied.

Detailed description

The OLP as the primary outcome measurement will be evaluated after insertion of the LMA in each group. We hypothesize that there will be a difference of 4 cm H2O between the 2 masks, because of the different material and slightly different form of the masks. Secondary outcomes will be measured after insertion of the LMA as by protocol. Finally postoperative airway morbidity will be evaluated 3 hours after removal of the LMA.

Conditions

Interventions

TypeNameDescription
DEVICEProtectorAll patients which are assigned to the Protector are studied with this laryngeal mask
DEVICESupremeAll patients which are assigned to the Supreme are studied with this laryngeal mask

Timeline

Start date
2017-07-12
Primary completion
2017-11-28
Completion
2017-11-28
First posted
2017-07-11
Last updated
2017-12-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03214497. Inclusion in this directory is not an endorsement.

Protector™ Versus Supreme® Laryngeal Mask Airway (NCT03214497) · Clinical Trials Directory